Viewing Study NCT05929768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:43 PM
Ignite Modification Date: 2026-01-02 @ 1:40 AM
Study NCT ID: NCT05929768
Status: RECRUITING
Last Update Posted: 2025-11-05
First Post: 2023-06-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Sponsor: SWOG Cancer Research Network
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage I Breast Cancer AJCC v8 View
None Anatomic Stage II Breast Cancer AJCC v8 View
None Anatomic Stage IIIA Breast Cancer AJCC v8 View
None Anatomic Stage IIIB Breast Cancer AJCC v8 View
None Early Stage Triple-Negative Breast Carcinoma View
Keywords: